<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39423219</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-2594</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Magnetic resonance in medicine</Title><ISOAbbreviation>Magn Reson Med</ISOAbbreviation></Journal><ArticleTitle>Mapping the amplitude and phase of dissolved <sup>129</sup>Xe red blood cell signal oscillations with keyhole spectroscopic lung imaging.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/mrm.30296</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To assess the regional amplitude and phase of dissolved <sup>129</sup>Xe red blood cell (RBC) signal oscillations in the lung vasculature with keyhole spectroscopic imaging and to compare with previous methodology, which does not account for oscillation phase.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS"><sup>129</sup>Xe gas transfer was measured with a four-echo 3D radial spectroscopic imaging sequence. Keyhole reconstruction-based RBC signal oscillation amplitude mapping was applied retrospectively to data acquired from 28 healthy volunteers, 4 chronic thromboembolic pulmonary hypertension (CTEPH) patients, and 5 patients who were hospitalized due to COVID-19 pneumonia and had residual lung abnormalities. Using a sliding window keyhole reconstruction, maps of RBC oscillation amplitude were corrected for regional phase difference. Repeatability of the phase-adjusted oscillation amplitude was assessed in 8 healthy volunteers across three scans.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">With sliding window keyhole reconstruction, regional phase differences were observed in the RBC signal oscillations: mean phase = (0.27 ± 0.19) rad in healthy volunteers, (0.24 ± 0.13) rad in CTEPH patients, and (0.33 ± 0.19) rad in patients with post-COVID-19 residual lung abnormality. The oscillation amplitude and phase maps were more heterogeneous (i.e., they showed increased coefficient of variation) for the CTEPH patients. The RBC oscillation amplitude was repeatable, and the mean three-scan coefficient of variation was smaller when the phase adjustment was made (0.07 ± 0.04 compared with 0.16 ± 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sliding window keyhole reconstruction of radial dissolved <sup>129</sup>Xe imaging reveals regional phase differences in the RBC oscillations, which are not captured when performing two phase keyhole reconstruction. This regional phase information may reflect the hemodynamic effect of the cardiac pulse wave in the pulmonary microvasculature.</AbstractText><CopyrightInformation>© 2024 The Author(s). Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pilgrim-Morris</LastName><ForeName>Jemima H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0009-0000-5343-2446</Identifier><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collier</LastName><ForeName>Guilhem J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0002-1874-4775</Identifier><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takigawa</LastName><ForeName>Mika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Scarlett</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Roger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0717-4551</Identifier><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norquay</LastName><ForeName>Graham</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4108-9035</Identifier><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Neil J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0001-8358-394X</Identifier><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Jim M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>POLARIS, Section of Medical Imaging and Technologies, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M008894/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W006111/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>EP/X025187/1</GrantID><Agency>Engineering and Physical Sciences Research Council</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Magn Reson Med</MedlineTA><NlmUniqueID>8505245</NlmUniqueID><ISSNLinking>0740-3194</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiogenic oscillations</Keyword><Keyword MajorTopicYN="N">hyperpolarized 129Xe</Keyword><Keyword MajorTopicYN="N">lung MRI</Keyword><Keyword MajorTopicYN="N">pulmonary microvasculature</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39423219</ArticleId><ArticleId IdType="doi">10.1002/mrm.30296</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Marshall H, Stewart NJ, Chan HF, Rao M, Norquay G, Wild JM. In vivo methods and applications of xenon‐129 magnetic resonance. Prog Nucl Magn Reson Spectrosc. 2021;122:42‐62.</Citation></Reference><Reference><Citation>Kaushik SS, Robertson SH, Freeman MS, et al. Single‐breath clinical imaging of hyperpolarized Xe‐129 in the airspaces, barrier, and red blood cells using an interleaved 3D radial 1‐point Dixon Acquisition. Magn Reson Med. 2016;75:1434‐1443.</Citation></Reference><Reference><Citation>Mummy DG, Bier EA, Wang ZY, et al. Hyperpolarized Xe‐129 MRI and spectroscopy of gas‐exchange abnormalities in nonspecific interstitial pneumonia. Radiology. 2021;301:211‐220.</Citation></Reference><Reference><Citation>Wang JM, Robertson SH, Wang ZY, et al. Using hyperpolarized Xe‐129 MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis. Thorax. 2018;73:21‐28.</Citation></Reference><Reference><Citation>Qing K, Ruppert K, Jiang Y, et al. Regional mapping of gas uptake by blood and tissue in the human lung using hyperpolarized xenon‐129 MRI. J Magn Reson Imaging. 2014;39:346‐359.</Citation></Reference><Reference><Citation>Wang ZY, Bier EA, Swaminathan A, et al. Diverse cardiopulmonary diseases are associated with distinct xenon magnetic resonance imaging signatures. Eur Respir J. 2019;54:1900831.</Citation></Reference><Reference><Citation>Qing K, Mugler JP, Altes TA, et al. Assessment of lung function in asthma and COPD using hyperpolarized Xe‐129 chemical shift saturation recovery spectroscopy and dissolved‐phase MRI. NMR Biomed. 2014;27:1490‐1501.</Citation></Reference><Reference><Citation>Stewart NJ, Leung G, Norquay G, et al. Experimental validation of the hyperpolarized Xe‐129 chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magn Reson Med. 2015;74:196‐207.</Citation></Reference><Reference><Citation>Collier GJ, Eaden JA, Hughes P JC, et al. Dissolved 129Xe lung MRI with four‐echo 3D radial spectroscopic imaging: Quantification of regional gas transfer in idiopathic pulmonary fibrosis. Magn Reson Med. 2020;85:2622–2633.</Citation></Reference><Reference><Citation>Mugler JP, Altes TA. Hyperpolarized 129Xe MRI of the human lung. J Magn Reson Imaging. 2013;37:313‐331.</Citation></Reference><Reference><Citation>Ruppert K, Altes TA, Mata JF, Ruset IC, Hersman FW, Mugler JP III. Detecting pulmonary capillary blood pulsations using hyperpolarized xenon‐129 chemical shift saturation recovery (CSSR) MR spectroscopy. Magn Reson Med. 2016;75:1771‐1780.</Citation></Reference><Reference><Citation>Venkatesh AK, Hong KS, Kubatina L, et al. Direct observation of the transport of 129Xe from the lung‐gas to the tissue and the blood. In Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, Scotland. 2001. Abstract 0954.</Citation></Reference><Reference><Citation>Norquay G, Leung G, Stewart NJ, Wolber J, Wild JM. 129Xe chemical shift in human blood and pulmonary blood oxygenation measurement in humans using hyperpolarized129Xe NMR. Magn Reson Med. 2017;77:1399‐1408.</Citation></Reference><Reference><Citation>Bechtel A, Lu JL, Mummy D, et al. Establishing a hemoglobin adjustment for 129Xe gas exchange MRI and MRS. Magn Reson Med. 2023;90:1555‐1568.</Citation></Reference><Reference><Citation>Weatherley ND, Eaden JA, Hughes PJC, et al. Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast‐enhanced perfusion MRI. Thorax. 2021;76:144‐151.</Citation></Reference><Reference><Citation>Hueper K, Vogel‐Claussen J, Parikh MA, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD study. Am J Respir Crit Care Med. 2015;192:570‐580.</Citation></Reference><Reference><Citation>Bier EA, Robertson SH, Schrank GM, et al. A protocol for quantifying cardiogenic oscillations in dynamic (129) Xe gas exchange spectroscopy: the effects of idiopathic pulmonary fibrosis. NMR Biomed. 2019;32:e4029.</Citation></Reference><Reference><Citation>Bier EA, Alenezi F, Lu J, et al. Noninvasive diagnosis of pulmonary hypertension with hyperpolarised (129)Xe magnetic resonance imaging and spectroscopy. Eur Respir J Open Res. 2022;8:00035‐2022.</Citation></Reference><Reference><Citation>Vlahos I, Jacobsen MC, Godoy MC, Stefanidis K, Layman RR. Dual‐energy CT in pulmonary vascular disease. Br J Radiol. 2022;95:20210699.</Citation></Reference><Reference><Citation>Johns CS, Kiely DG, Swift AJ. Novel imaging techniques in pulmonary hypertension. Curr Opin Cardiol. 2018;33:587‐593.</Citation></Reference><Reference><Citation>Niedbalski PJ, Bier EA, Wang Z, Willmering MM, Driehuys B, Cleveland ZI. Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI. J Appl Physiol. 2020;129:218‐229.</Citation></Reference><Reference><Citation>Lethmate R, Wajer FTAW, Crémillieux Y, van Ormondt D, Graveron‐Demilly D. Dynamic MR‐imaging with radial scanning, a Post‐acquisition keyhole approach. EURASIP J Adv Signal Process. 2003;2003:794878.</Citation></Reference><Reference><Citation>Lu J, Alenezi F, Bier E, et al. Optimized quantitative mapping of cardiopulmonary oscillations using hyperpolarized 129Xe gas exchange MRI: digital phantoms and clinical evaluation in CTEPH. Magn Reson Med. 2024;91:1541‐1555.</Citation></Reference><Reference><Citation>Cleveland ZI, Virgincar RS, Qi Y, Robertson SH, Degan S, Driehuys B. 3D MRI of impaired hyperpolarized Xe‐129 uptake in a rat model of pulmonary fibrosis. NMR Biomed. 2014;27:1502‐1514.</Citation></Reference><Reference><Citation>Kammerman J, Hahn AD, Cadman RV, Malkus A, Mummy D, Fain SB. Transverse relaxation rates of pulmonary dissolved‐phase hyperpolarized Xe‐129 as a biomarker of lung injury in idiopathic pulmonary fibrosis. Magn Reson Med. 2020;84:1857‐1867.</Citation></Reference><Reference><Citation>Collier GJ, Smith LJ, Saunders LC, et al. Age, sex, and lung volume dependence of dissolved xenon‐129 MRI gas exchange metrics. Magn Reson Med. 2024;92:1471‐1483.</Citation></Reference><Reference><Citation>Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least‐squares estimation (IDEAL): application with fast spin‐echo imaging. Magn Reson Med. 2005;54:636‐644.</Citation></Reference><Reference><Citation>Saunders LC, Collier GJ, Chan H‐F, et al. Longitudinal lung function assessment of patients hospitalized with COVID‐19 using 1H and 129Xe lung MRI. Chest. 2023;164:700‐716.</Citation></Reference><Reference><Citation>Marshall H, Smith L, Biancardi A, et al. A comparison of 129Xe MRI and advanced lung function testing in patients with asthma and /or COPD: the NOVELTY ADPro substudy. Eur Respir J. 2021;58:PA1872.</Citation></Reference><Reference><Citation>Weatherley ND, Stewart NJ, Chan H‐F, et al. Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax. 2019;74:500‐502.</Citation></Reference><Reference><Citation>Grist JT, Chen M, Collier GJ, et al. Hyperpolarized Xe‐129 MRI abnormalities in dyspneic patients 3 months after COVID‐19 pneumonia: preliminary results. Radiology. 2021;301:E353‐E360.</Citation></Reference><Reference><Citation>Grist JT, Collier GJ, Walters H, et al. Lung abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID. Radiology. 2022;305:709‐717.</Citation></Reference><Reference><Citation>Norquay G, Collier GJ, Rao M, Stewart NJ, Wild JM. 129Xe‐Rb spin‐exchange optical pumping with high photon efficiency. Phys Rev Lett. 2018;121:153201.</Citation></Reference><Reference><Citation>Ruppert K, Amzajerdian F, Hamedani H, et al. Assessment of flip angle‐TR equivalence for standardized dissolved‐phase imaging of the lung with hyperpolarized 129Xe MRI. Magn Reson Med. 2019;81:1784‐1794.</Citation></Reference><Reference><Citation>Kaushik S, Freeman M, Yoon S, et al. Measuring diffusion limitation with a perfusion‐limited gas—hyperpolarized 129Xe gas‐transfer spectroscopy in patients with idiopathic pulmonary fibrosis. J Appl Physiol (1985). 2014;117:577‐585.</Citation></Reference><Reference><Citation>Wiesinger F, Weidl E, Menzel MI, et al. IDEAL spiral CSI for dynamic metabolic MR imaging of hyperpolarized [1‐13C]pyruvate. Magn Reson Med. 2012;68:8‐16.</Citation></Reference><Reference><Citation>Beatty PJ, Nishimura DG, Pauly JM. Rapid gridding reconstruction with a minimal oversampling ratio. IEEE Trans Med Imaging. 2005;24:799‐808.</Citation></Reference><Reference><Citation>Zwart NR, Johnson KO, Pipe JG. Efficient sample density estimation by combining gridding and an optimized kernel. Magn Reson Med. 2012;67:701‐710.</Citation></Reference><Reference><Citation>Rose A. Vision: Human and Electronic. Plenum Press; 1973.</Citation></Reference><Reference><Citation>Norquay G, Collier GJ, Wild JM. Temporal correlation of alveolar‐capillary 129Xe signal dynamics with the cardiac cycle. In Proceedings of the 29th Annual Meeting of ISMRM. 2021. Abstract 3564.</Citation></Reference><Reference><Citation>Costelle A, Lu J, Bechtel A, et al. Quantifying cardiogenic oscillations of hyperpolarized Xe gas exchange MR spectra in a healthy reference cohort. In Proceedings of the 31st Annual Meeting of ISMRM, Toronto, Canada. 2023. Abstract 0857.</Citation></Reference><Reference><Citation>Karatzas NB, Lee Gde J. Propagation of blood flow pulse in the normal human pulmonary arterial system. Analysis of the pulsatile capillary flow. Circ Res. 1969;25:11‐21.</Citation></Reference><Reference><Citation>Littler WA, Bojorges‐Bueno R, Banks J. Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy. Thorax. 1974;29:567‐570.</Citation></Reference><Reference><Citation>Henderson AC, Sá RC, Theilmann RJ, Buxton RB, Prisk GK, Hopkins SR. The gravitational distribution of ventilation‐perfusion ratio is more uniform in prone than supine posture in the normal human lung. J Appl Physiol. 2013;115:313‐324.</Citation></Reference><Reference><Citation>Wasserman K, Butler J, Kessel AV. Factors affecting the pulmonary capillary blood flow pulse in man. J Appl Physiol. 1966;21:890‐900.</Citation></Reference><Reference><Citation>Pepke‐Zaba J, Ghofrani H‐A, Hoeper MM. Medical management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26:160107.</Citation></Reference><Reference><Citation>Pöhler GH, Löffler F, Klimeš F, et al. Validation of phase‐resolved functional lung (PREFUL) magnetic resonance imaging pulse wave transit time compared to echocardiography in chronic obstructive pulmonary disease. J Magn Reson Imaging. 2022;56:605‐615.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>